Wolverine Trading’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,760
Closed -$428K 4934
2024
Q2
$408K Sell
4,760
-230
-5% -$19.3K ﹤0.01% 3047
2024
Q1
$412K Buy
+4,990
New +$365K ﹤0.01% 3039
2023
Q2
Sell
-5,696
Closed -$303K 4402
2023
Q1
$303K Buy
+5,696
New +$332K ﹤0.01% 3005
2022
Q2
Sell
-10,933
Closed -$619K 4798
2022
Q1
$619K Buy
10,933
+6,247
+133% +$326K ﹤0.01% 2972
2021
Q4
$246K Sell
4,686
-9,214
-66% -$475K ﹤0.01% 4412
2021
Q3
$846K Buy
13,900
+10,038
+260% +$632K ﹤0.01% 3210
2021
Q2
$242K Buy
+3,862
New +$257K ﹤0.01% 4749
2020
Q1
Sell
-6,220
Closed -$359K 4765
2019
Q4
$343K Buy
+6,220
New +$338K ﹤0.01% 3444
2017
Q1
Sell
-20,362
Closed -$669K 4438
2016
Q4
$668K Buy
20,362
+7,632
+60% +$248K ﹤0.01% 2302
2016
Q3
$410K Buy
+12,730
New +$412K ﹤0.01% 2819

Other funds holding EHC

Wolverine Trading's EHC Position: Q3 2024 in Review

Wolverine Trading sold out of Encompass Health (EHC) in Q3 2024, closing a stake of 4,760 shares — an estimated $428K sold.

Wolverine Trading first reported a position in EHC in Q3 2016 and held it in 10 quarters. The position peaked at $846K in Q3 2021. 483 funds tracked by Wall St. Rank hold EHC as of Q3 2024.

  • Wolverine Trading reported no remaining Encompass Health position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 4,760 Encompass Health shares in Q3 2024, an estimated $428K.
  • Wolverine Trading first reported a position in Encompass Health in Q3 2016 and held it in 10 quarters.
  • Wolverine Trading's Encompass Health position peaked at $846K in Q3 2021.
  • 483 funds tracked by Wall St. Rank held Encompass Health as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.